| ng to scientific studies, three million people die from | | | | rapidly. |
| Tuberculosis every year. A number of around eight | | | | One worrying issue of the TBC condition is the |
| million new discovered Tuberculosis conditions appear | | | | development of resistance to antibiotics due to fast |
| per year and 95% is estimated to be in developing | | | | bacterial mutations. The resistance phenomenon |
| areas. Countries like those in South America, Africa or | | | | increases the risk of reoccurrence and makes |
| Asia have the highest susceptibility to Tuberculosis | | | | recurrent cases more dangerous. Administering one |
| due to the low living standards and the bad economic | | | | single drug in the treatment of Tuberculosis tends to |
| and social conditions. | | | | be dangerous as one single mutant bacillus in enough |
| Although the risk of Tuberculosis infection has | | | | to trigger antibiotic-resistant Tuberculosis. Nowadays |
| decreased in the 1980’, in the 1990’ it | | | | doctors prescribe the standard medication for this |
| already began to arise because of the high rate of | | | | condition: Rifampicin, Isoniazide, Pyrazinamide and |
| immigration from countries with increased number of | | | | Ethambutol. Also Streptomycin is efficient in treating |
| cases. Immigrant communities all difficult to observe, | | | | active Tuberculosis. This medication schedule will |
| control or treat, because of the many differences | | | | prevent the multiplication of all strains of |
| between different races and cultures. | | | | Mycobacterium bacteria. |
| Immunity plays a tremendous role in prevention and | | | | In our times Tuberculosis is well kept under control |
| treatment of Tuberculosis. A healthy immune system | | | | by good organized care systems in the civilized world. |
| lowers the risk of catching Tuberculosis to 1 in 10 | | | | But slow developing countries are at high risk of an |
| cases per year and only seldom an infected healthy | | | | epidemic because of the low possibilities to prevent, |
| organism gets to develop the active condition. HIV+ | | | | supervise and treat Tuberculosis cases. Further |
| patients have a suppressed and weaken immune | | | | laboratory studies are necessary to establish an |
| system and are mostly incapable to fight | | | | efficient anti-Tuberculosis vaccine that might reduce |
| Mycobacterium. 1 in 10 patients with AIDS will surely | | | | the risk of catching the bacillus. The medical world |
| suffer from active tuberculin infection, and from | | | | must improve the diagnose methods as well as the |
| those with a positive skin test 1 in 2 will develop | | | | available medication in order to face the hard battle |
| Tuberculosis. Epidemiological implications are very | | | | with Tuberculosis. |
| concerning as HIV cases tend to increase very | | | | |